ACAD
ACADIA Pharmaceuticals Inc
NASDAQ: ACAD · HEALTHCARE · BIOTECHNOLOGY
$22.20
-2.07% today
Updated 2026-04-29
Market cap
$3.80B
P/E ratio
9.65
P/S ratio
3.55x
EPS (TTM)
$2.30
Dividend yield
—
52W range
$14 – $28
Volume
1.9M
ACADIA Pharmaceuticals Inc (ACAD) Financial statements
SEC filings — annual and quarterly data.
Profit margin
36.50%
Operating margin
6.12%
ROE
39.90%
ROA
4.76%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $8.13M | $-45.05M | 100.00% | -603.15% | -553.89% |
| 2007 | $7.55M | $-56.39M | 100.00% | -829.31% | -746.39% |
| 2008 | $1.59M | $-64.24M | 100.00% | -4,212.45% | -4,040.50% |
| 2009 | $6.40M | $-45.15M | 100.00% | -710.55% | -705.50% |
| 2010 | $42.13M | $15.14M | 100.00% | 35.82% | 35.93% |
| 2011 | $2.07M | $-22.77M | 100.00% | -1,105.56% | -1,101.35% |
| 2012 | $4.91M | $-20.85M | 100.00% | -425.64% | -424.88% |
| 2013 | $1.15M | $-37.95M | -2,233.80% | -3,344.72% | -3,314.24% |
| 2014 | $120000.00 | $-92.47M | 100.00% | -77,691.67% | -77,062.50% |
| 2015 | $61000.00 | $-164.44M | 100.00% | -269,855.74% | -269,578.69% |
| 2016 | $17.33M | $-271.39M | 74.58% | -1,574.14% | -1,565.94% |
| 2017 | $124.90M | $-289.40M | 89.54% | -234.11% | -231.71% |
| 2018 | $223.81M | $-245.19M | 91.81% | -110.56% | -109.56% |
| 2019 | $339.08M | $-235.26M | 94.22% | -72.71% | -69.38% |
| 2020 | $441.75M | $-281.58M | 95.35% | -64.87% | -63.74% |
| 2021 | $484.14M | $-167.87M | 96.05% | -35.20% | -34.67% |
| 2022 | $517.24M | $-215.97M | 98.03% | -43.23% | -41.76% |
| 2023 | $726.44M | $-61.29M | 93.70% | -10.10% | -8.44% |
| 2024 | $957.80M | $226.45M | 91.46% | 24.10% | 23.64% |
| 2025 | $1.07B | $391.00M | 91.69% | 9.78% | 36.49% |